Skip to main content
. Author manuscript; available in PMC: 2010 Jan 15.
Published in final edited form as: J Comp Neurol. 1996 May 20;369(1):93–108. doi: 10.1002/(SICI)1096-9861(19960520)369:1<93::AID-CNE7>3.0.CO;2-F

Fig. 9.

Fig. 9

Representative coronal sections of GFAP-IS from each experimental drug group. All abbreviations are as in Figure 4. Left-right neocortical GFAP-IS staining differences were induced in each group despite the pretreatment with drugs that influence eicosanoid or NO metabolism. Quantitative OD analyses (e.g., Fig. 10) confirmed this impression.